Published in N Engl J Med on May 22, 2012
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis (2013) 5.00
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol (2013) 4.38
Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence (2013) 1.10
Novel pharmacologic treatment attenuates septic shock and improves long-term survival. Surgery (2013) 1.09
Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis. EMBO Mol Med (2013) 1.05
Heparanase mediates renal dysfunction during early sepsis in mice. Physiol Rep (2013) 1.00
MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis. Infect Immun (2014) 1.00
Protection against LPS-induced acute lung injury by a mechanism-based inhibitor of NADPH oxidase (type 2). Am J Physiol Lung Cell Mol Physiol (2014) 0.94
IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS. Shock (2016) 0.91
Intestine-specific Mttp deletion decreases mortality and prevents sepsis-induced intestinal injury in a murine model of Pseudomonas aeruginosa pneumonia. PLoS One (2012) 0.91
Selective inhibition of histone deacetylase 6 alters the composition of circulating blood cells in a lethal septic model. J Surg Res (2014) 0.89
Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. J Immunol (2013) 0.86
The wingless-related integration site-5a/secreted frizzled-related protein-5 system is dysregulated in human sepsis. Clin Exp Immunol (2015) 0.82
Selective histone deacetylase 6 inhibition prolongs survival in a lethal two-hit model. J Surg Res (2015) 0.81
Myeloid-derived suppressor cells in sepsis. Biomed Res Int (2014) 0.79
Mitochondrial Dysfunction, Depleted Purinergic Signaling, and Defective T Cell Vigilance and Immune Defense. J Infect Dis (2015) 0.79
Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis. Surgery (2014) 0.79
Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model. J Trauma Acute Care Surg (2016) 0.79
Antimicrobial peptides for gram-negative sepsis: a case for the polymyxins. Front Immunol (2012) 0.78
Lipopolysaccharide-Induced CD300b Receptor Binding to Toll-like Receptor 4 Alters Signaling to Drive Cytokine Responses that Enhance Septic Shock. Immunity (2016) 0.77
Heterogeneity among septic shock patients in a set of immunoregulatory markers. Eur J Clin Microbiol Infect Dis (2013) 0.76
Purinergic Signaling and the Immune Response in Sepsis: A Review. Clin Ther (2016) 0.76
Protective effect of Cl-amidine against CLP-induced lethal septic shock in mice. Sci Rep (2016) 0.75
Milk fat globule-epidermal growth factor-factor VIII-derived peptide MSP68 is a cytoskeletal immunomodulator of neutrophils that inhibits Rac1. J Surg Res (2016) 0.75
Prevention of organ dysfunction in septic shock: still looking for an effective treatment. J Thorac Dis (2016) 0.75
Recombinant human annexin A5: a novel drug candidate for treatment of sepsis? Crit Care Med (2014) 0.75
Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med (2012) 9.19
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis (2004) 20.99
Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med (2002) 5.39
Antibiotic prevention of acute exacerbations of COPD. N Engl J Med (2012) 4.11
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis (2003) 3.53
Managing SARS amidst uncertainty. N Engl J Med (2003) 2.87
Screening inpatients for MRSA--case closed. N Engl J Med (2013) 2.44
Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol (2008) 2.27
Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob (2004) 2.24
Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J (2003) 2.22
Bacteremias: a leading cause of death. Arch Med Res (2005) 2.09
Positive deviance: a new strategy for improving hand hygiene compliance. Infect Control Hosp Epidemiol (2010) 1.64
Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J Infect (2011) 1.61
Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol (2011) 1.54
Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis (2005) 1.54
Infections associated with religious rituals. Int J Infect Dis (2013) 1.44
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. J Infect (2005) 1.43
Patient-to-patient transmission of hepatitis C virus. Ann Intern Med (2005) 1.40
Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting. PLoS One (2011) 1.35
Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis (2006) 1.31
Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis (2007) 1.22
Methicillin-resistant Staphylococcus aureus: the superbug. Int J Infect Dis (2010) 1.20
Minimizing surgical-site infections. N Engl J Med (2010) 1.18
Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis (2007) 1.17
Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis (2013) 1.17
Successful prevention of ventilator-associated pneumonia in an intensive care setting. Am J Infect Control (2009) 1.16
Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis (2004) 1.12
Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature. Clin Infect Dis (2005) 1.11
Measuring rates of hand hygiene adherence in the intensive care setting: a comparative study of direct observation, product usage, and electronic counting devices. Infect Control Hosp Epidemiol (2010) 1.11
Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol (2007) 1.10
A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections. Infect Control Hosp Epidemiol (2006) 1.09
Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother (2006) 1.08
Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother (2008) 1.08
Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr (2007) 1.08
Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era. Am J Infect Control (2010) 1.06
Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection. J Clin Microbiol (2006) 1.06
Post-malaria neurological syndrome: a case report and review of the literature. J Travel Med (2009) 1.05
A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting. BMC Infect Dis (2012) 1.02
A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms. Am J Infect Control (2007) 1.02
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci. BMC Infect Dis (2006) 1.01
Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. Int J Antimicrob Agents (2007) 0.98
Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol (2004) 0.97
Infection control and the prevention of nosocomial infections in the intensive care unit. Semin Respir Crit Care Med (2006) 0.96
Team-based prevention of catheter-related infections. N Engl J Med (2006) 0.96
A crossover trial of antimicrobial scrubs to reduce methicillin-resistant Staphylococcus aureus burden on healthcare worker apparel. Infect Control Hosp Epidemiol (2012) 0.96
Positive deviance: a program for sustained improvement in hand hygiene compliance. Am J Infect Control (2011) 0.95
Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections. Expert Rev Hematol (2009) 0.94
Antibiotic options for treating community-acquired MRSA. Expert Rev Anti Infect Ther (2008) 0.93
A multicenter study using positive deviance for improving hand hygiene compliance. Am J Infect Control (2013) 0.92
Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. BMC Infect Dis (2006) 0.92
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use. Emerg Infect Dis (2005) 0.90
Using theater to teach clinical empathy: a pilot study. J Gen Intern Med (2007) 0.90
Nosocomial bloodstream infections in Brazilian pediatric patients: microbiology, epidemiology, and clinical features. PLoS One (2013) 0.88
Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis (2010) 0.88
Influence of state laws mandating reporting of healthcare-associated infections: the case of central line-associated bloodstream infections. Infect Control Hosp Epidemiol (2013) 0.88
Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections. J Clin Microbiol (2002) 0.87
Practices and an assessment of health care workers' perceptions of compliance with infection control knowledge of nosocomial infections. Am J Infect Control (2005) 0.87
Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit. Infect Control Hosp Epidemiol (2010) 0.87
High altitude headache: efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial. J Emerg Med (2003) 0.86
Controlled trial measuring the effect of a feedback intervention on hand hygiene compliance in a step-down unit. Infect Control Hosp Epidemiol (2008) 0.86
Surgeons do not listen: evaluation of compliance with antimicrobial stewardship program recommendations. Am Surg (2013) 0.85
Effect of contact precautions on wait time from emergency room disposition to inpatient admission. Infect Control Hosp Epidemiol (2011) 0.84
Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent. Expert Rev Anti Infect Ther (2006) 0.84
Targeted decolonization to prevent ICU infections. N Engl J Med (2013) 0.84
Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates. Microb Drug Resist (2012) 0.83
Nasal carriage of inducible dormant and community-associated methicillin-resistant Staphylococcus aureus in an ambulatory population of predominantly university students. Int J Infect Dis (2010) 0.82
The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control (2008) 0.82
Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis. J Clin Microbiol (2006) 0.81
R = 20: bias in the reporting of respiratory rates. Am J Emerg Med (2008) 0.81
Are gym surfaces reservoirs for Staphylococcus aureus? A point prevalence survey. Am J Infect Control (2012) 0.81
Preparing for 2009 H1N1 Influenza. N Engl J Med (2009) 0.81
Hand Hygiene: State-of-the-Art Review With Emphasis on New Technologies and Mechanisms of Surveillance. Curr Infect Dis Rep (2012) 0.81
Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection. BMC Infect Dis (2013) 0.80
Listening to SARS: lessons for infection control. Ann Intern Med (2003) 0.80
Improving the diagnosis of meningitis due to enterovirus and herpes simplex virus I and II in a tertiary care hospital. BMC Infect Dis (2013) 0.80
Comparison of the systemic inflammatory response syndrome between monomicrobial and polymicrobial Pseudomonas aeruginosa nosocomial bloodstream infections. BMC Infect Dis (2005) 0.80
Outcomes of patients with alcohol use disorders experiencing healthcare-associated infections. Alcohol Clin Exp Res (2011) 0.79
Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients. J Am Geriatr Soc (2006) 0.79
Positive Deviance: A New Tool for Infection Prevention and Patient Safety. Curr Infect Dis Rep (2013) 0.79
Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey. Infect Control Hosp Epidemiol (2012) 0.78
Lessons from severe acute respiratory syndrome (SARS): implications for infection control. Arch Med Res (2005) 0.78